The initiation of coverage by Stephens & Co. with an Overweight rating typically suggests a positive forecast for Illumina's stock performance. The announcement of a price target of $170, which is presumably above the current trading price, indicates an expectation of stock appreciation. This can lead to increased investor interest and potentially drive up the stock price in the short term.